Thymosin alpha-1 10mg vials explained: what the peptide is, how to reconstitute it, typical research dosing, side effects, and how it compares to TB-500.
Thymosin alpha-1 10mg is a vial containing 10 milligrams of synthetic thymosin alpha-1, a 28-amino-acid peptide normally supplied as a lyophilized powder for laboratory research. The 10mg figure describes the total peptide mass in the vial — it is not a dose, and it is not the number of servings. In the United States, thymosin alpha-1 is not FDA-approved for human use and is sold as a research chemical rather than a prescription medicine.
That single fact shapes every practical question about the product: how much diluent to add, how long a vial lasts, and how it differs from other peptides with similar names.
What the 10mg Strength Actually Tells You
A 10mg vial is a bulk quantity. The concentration you end up with depends entirely on how much bacteriostatic water or sterile water you add.
- Total peptide: 10 mg of thymosin alpha-1, freeze-dried.
- Concentration: total milligrams divided by milliliters of diluent added.
- Yield: a 10mg vial reconstituted with 5 mL gives 5 mL of solution at 2 mg/mL.
| Bacteriostatic water added | Concentration | Volume equal to 1.6 mg | Volume equal to 1 mg |
|---|---|---|---|
| 1 mL | 10 mg/mL | 0.16 mL | 0.10 mL |
| 2 mL | 5 mg/mL | 0.32 mL | 0.20 mL |
| 4 mL | 2.5 mg/mL | 0.64 mL | 0.40 mL |
| 5 mL | 2 mg/mL | 0.80 mL | 0.50 mL |
| 10 mL | 1 mg/mL | 1.60 mL | 1.00 mL |
The 1.6 mg column is included because 1.6 mg is the dose used in the pharmaceutical formulation approved in many countries outside the United States.
Thymosin Alpha-1 Dosing in Published Research
Zadaxin, the pharmaceutical-grade brand of thymosin alpha-1, is approved in more than 35 countries and is typically given as 1.6 mg subcutaneously twice weekly in chronic hepatitis B and hepatitis C trials. Sepsis and oncology studies have used similar or somewhat higher amounts on varied schedules.
The most commonly cited clinical dose of thymosin alpha-1 is 1.6 mg administered subcutaneously twice per week.
A thymosin alpha 1 dosage chart published by a vendor is not a clinical guideline, and research-chemical products are not manufactured to the same standards as approved drugs. Anyone weighing real use should work with a licensed healthcare professional rather than copying a protocol from a forum.
Thymosin Alpha-1 Benefits Studied in Clinical Trials
Thymosin alpha-1 acts as an immune modulator rather than a direct antiviral or antibiotic. Researchers study its effects on T-cell maturation, natural killer cell activity, and dendritic cell signaling.
The thymosin alpha 1 benefits reported in the literature are narrow and condition-specific:
- Improved immune response in chronic hepatitis B and C when combined with standard therapy
- Reduced mortality in some sepsis trials
- Stronger vaccine responses in older adults
- Adjunctive use in certain cancers and in patients with suppressed immunity
Thymosin alpha-1 has been studied as an immune modulator, not as a cure for any disease.
Many popular claims, especially those involving athletic performance and recovery, are not supported by controlled human data.
Thymosin Alpha-1 Side Effects and Safety
In clinical trials, thymosin alpha-1 has generally been well tolerated. Most reports of thymosin alpha 1 side effects describe injection-site redness or discomfort, mild flu-like symptoms, fatigue, low-grade fever, and occasional gastrointestinal upset.
Serious reactions appear rare, but standard cautions apply. People with autoimmune conditions, organ transplants, or ongoing immunosuppressive therapy may face higher risk, and pregnant or breastfeeding individuals should avoid the peptide.
Thymosin alpha-1 is not FDA-approved for human use in the United States, and research-grade vials are not guaranteed to be sterile, pure, or accurately dosed.
Storage and Handling of a 10mg Vial
- Store lyophilized powder in the refrigerator or freezer, protected from light.
- Avoid repeated temperature swings, and let the vial reach room temperature before reconstituting.
- Swirl gently instead of shaking, since shaking can damage the peptide.
- Refrigerate reconstituted solution at 2 to 8 °C and follow the supplier's stability guidance.
- Discard any solution that looks cloudy or contains visible particles.
Thymosin Alpha-1 vs Thymosin Beta-4 (TB-500)
The two peptides share a name fragment and little else. The difference is obvious when you set thymosin alpha 1 vs thymosin beta 4 side by side.
| Feature | Thymosin alpha-1 | Thymosin beta-4 (TB-500) |
|---|---|---|
| Length | 28 amino acids | 43 amino acids |
| Main research focus | Immune modulation, T-cell function | Cell migration, actin regulation, tissue repair |
| Common vial sizes | 5 mg and 10 mg | 5 mg and 10 mg |
| Typical research route | Subcutaneous injection | Subcutaneous or intramuscular injection |
| US regulatory status | Not FDA-approved for human use | Not FDA-approved for human use |
A search for tb-500 thymosin beta-4 10mg leads to a peptide studied for soft-tissue repair, not immune support, so the two should never be treated as interchangeable.
Bottom Line
A thymosin alpha-1 10mg vial is a bulk research quantity of an immune-modulating peptide, and the 10mg label describes peptide mass rather than dose. Reconstitution volume determines concentration, 1.6 mg twice weekly is the most commonly cited clinical dose, and US buyers are dealing with an unapproved research chemical.
Anyone considering thymosin alpha-1 for a health condition should speak with a physician about approved alternatives first.
Frequently Asked Questions
What is thymosin alpha-1 10mg used for?
In countries where it is approved as Zadaxin, thymosin alpha-1 is used for chronic hepatitis B and C and as an immune adjuvant. In the United States it is not FDA-approved for human use, so 10mg vials sold online are labeled for laboratory research only. Studies have also examined it in sepsis and as an adjunct in some cancers.
How much bacteriostatic water do I add to a 10mg thymosin alpha-1 vial?
The amount depends on the concentration you want. Adding 1 mL gives 10 mg/mL, 2 mL gives 5 mg/mL, and 5 mL gives 2 mg/mL. At 10 mg/mL, a 1.6 mg amount equals 0.16 mL of solution.
Is thymosin alpha-1 the same as TB-500?
No. Thymosin alpha-1 is a 28-amino-acid peptide studied for immune modulation, while TB-500 is a fragment of thymosin beta-4, a 43-amino-acid peptide studied for cell migration and tissue repair. They have different mechanisms, different research uses, and should not be substituted for one another.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.